Cargando…
Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study
Given the current scarcity of curative treatment of COVID-19, the search for an effective treatment modality among all available medications has become a priority. This study aimed at investigating the role of functional inhibitors of acid sphingomyelinase (FIASMAs) on in-hospital COVID-19 mortality...
Autores principales: | Darquennes, Gil, Le Corre, Pascal, Le Moine, Olivier, Loas, Gwenolé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998809/ https://www.ncbi.nlm.nih.gov/pubmed/33799977 http://dx.doi.org/10.3390/ph14030226 |
Ejemplares similares
-
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
por: Loas, Gwenolé, et al.
Publicado: (2021) -
Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection
por: Le Corre, Pascal, et al.
Publicado: (2022) -
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension
por: Loas, Gwenolé, et al.
Publicado: (2022) -
Suicidal Ideations in Major Depressed Subjects: Role of the Temporal Dynamics of Anhedonia
por: Darquennes, Gil, et al.
Publicado: (2023) -
Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach
por: Naz, Aliza, et al.
Publicado: (2023)